Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CROX Stock Summary
Top 10 Correlated ETFs
CROX
In the News
CROX Financial details
Company Rating
Strong Buy
Market Cap
7.59B
Income
792.57M
Revenue
3.96B
Book val./share
24.01
Cash/share
2.47
Dividend
-
Dividend %
-
Employees
7.03K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
10.24
Forward P/E
-
PEG
2.2
P/S
2.05
P/B
5.58
P/C
49.02
P/FCF
9.96
Quick Ratio
0.69
Current Ratio
1.3
Debt / Equity
1.19
LT Debt / Equity
1.13
-
-
EPS (TTM)
12.93
EPS next Y
-
EPS next Q
-
EPS this Y
46.37%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
50%
Revenue last 5Y
26.35%
Revenue Q/Q
-8.19%
EPS Q/Q
44.48%
-
-
-
-
SMA20
-4.23%
SMA50
24.44%
SMA100
39.96%
Inst Own
67.66%
Inst Trans
0.76%
ROA
17%
ROE
66%
ROC
0.27%
Gross Margin
56%
Oper. Margin
26%
Profit Margin
20%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
74.0-151.32
52W High
-19.81%
52W Low
+63.62%
RSI
36.98
Rel Volume
0.56
Avg Volume
1.28M
Volume
715.48K
Perf Week
-5.57%
Perf Month
0.57%
Perf Quarter
38.35%
Perf Half Y
38.81%
-
-
-
-
Beta
2.015
-
-
Volatility
3.62%, 7.72%
Prev Close
1.47%
Price
121.08
Change
-1.47%
CROX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 17.49 | 20.57 | 37.04 | 58.07 | 64.55 | |
Net income per share | 1.7 | 4.64 | 11.62 | 8.82 | 12.91 | |
Operating cash flow per share | 1.28 | 3.96 | 9.08 | 9.85 | 15.16 | |
Free cash flow per share | 0.76 | 3.34 | 8.18 | 8.15 | 13.27 | |
Cash per share | 1.54 | 2.02 | 3.41 | 3.13 | 2.43 | |
Book value per share | 1.87 | 4.31 | 0.23 | 13.36 | 23.68 | |
Tangible book value per share | 1.18 | 3.73 | -0.26 | -27.72 | -17.11 | |
Share holders equity per share | 1.87 | 4.31 | 0.23 | 13.36 | 23.68 | |
Interest debt per share | 5.72 | 5.64 | 15.77 | 44.61 | 30.76 | |
Market cap | 2.95B | 4.22B | 8.01B | 6.64B | 5.73B | |
Enterprise value | 3.23B | 4.46B | 8.76B | 9.04B | 7.58B | |
P/E ratio | 24.66 | 13.5 | 11.04 | 12.29 | 7.23 | |
Price to sales ratio | 2.39 | 3.05 | 3.46 | 1.87 | 1.45 | |
POCF ratio | 32.76 | 15.82 | 14.12 | 11.01 | 6.16 | |
PFCF ratio | 55.21 | 18.78 | 15.67 | 13.3 | 7.04 | |
P/B Ratio | 22.34 | 14.53 | 568.75 | 8.12 | 3.94 | |
PTB ratio | 22.34 | 14.53 | 568.75 | 8.12 | 3.94 | |
EV to sales | 2.63 | 3.22 | 3.79 | 2.54 | 1.91 | |
Enterprise value over EBITDA | 21.06 | 18.39 | 12.21 | 10.15 | 6.89 | |
EV to operating cash flow | 35.94 | 16.71 | 15.44 | 14.99 | 8.15 | |
EV to free cash flow | 60.56 | 19.83 | 17.13 | 18.12 | 9.3 | |
Earnings yield | 0.04 | 0.07 | 0.09 | 0.08 | 0.14 | |
Free cash flow yield | 0.02 | 0.05 | 0.06 | 0.08 | 0.14 | |
Debt to equity | 2.98 | 1.29 | 68.42 | 3.17 | 1.19 | |
Debt to assets | 0.53 | 0.33 | 0.62 | 0.58 | 0.37 | |
Net debt to EBITDA | 1.86 | 0.98 | 1.05 | 2.7 | 1.68 | |
Current ratio | 1.65 | 1.69 | 1.72 | 1.6 | 1.3 | |
Interest coverage | 14.9 | 31.76 | 31.55 | 6.25 | 6.49 | |
Income quality | 0.75 | 0.85 | 0.78 | 1.12 | 1.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.02 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.4 | 0.39 | 0.24 | 0.21 | 0 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
Intangibles to total assets | 0.07 | 0.04 | 0.02 | 0.56 | 0.54 | |
Capex to operating cash flow | -0.41 | -0.16 | -0.1 | -0.17 | -0.12 | |
Capex to revenue | -0.03 | -0.03 | -0.02 | -0.03 | -0.03 | |
Capex to depreciation | -1.51 | -1.52 | -1.75 | -2.66 | -2.13 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
Graham number | 8.46 | 21.23 | 7.68 | 51.5 | 82.95 | |
ROIC | 0.18 | 0.38 | 0.64 | 0.17 | 0.27 | |
Return on tangible assets | 0.17 | 0.29 | 0.48 | 0.27 | 0.37 | |
Graham Net | -4.6 | -7.17 | -16.78 | -49.16 | -42.35 | |
Working capital | 168.16M | 201.26M | 278.33M | 384.7M | 212.41M | |
Tangible asset value | 83.23M | 251.28M | -16.32M | -1.7B | -1.05B | |
Net current asset value | -181.52M | -335.25M | -864.42M | -2.66B | -2.28B | |
Invested capital | 2.98 | 1.29 | 68.42 | 3.17 | 1.19 | |
Average receivables | 113.31M | 140.39M | 189.85M | 273.19M | 330.21M | |
Average payables | 86.49M | 104.27M | 137.46M | 196.48M | 245.9M | |
Average inventory | 148.26M | 173.57M | 194.32M | 342.54M | 428.3M | |
Days sales outstanding | 35.07 | 42.8 | 34.27 | 33.8 | 30.51 | |
Days payables outstanding | 56.97 | 64.72 | 66.26 | 49.71 | 53.37 | |
Days of inventory on hand | 102.34 | 100.5 | 87.25 | 101.56 | 78.75 | |
Receivables turnover | 10.41 | 8.53 | 10.65 | 10.8 | 11.96 | |
Payables turnover | 6.41 | 5.64 | 5.51 | 7.34 | 6.84 | |
Inventory turnover | 3.57 | 3.63 | 4.18 | 3.59 | 4.64 | |
ROE | 0.91 | 1.08 | 51.53 | 0.66 | 0.55 | |
Capex per share | -0.52 | -0.62 | -0.9 | -1.7 | -1.88 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.31 | 14.3 | 17.29 | 17.1 | 15.86 | |
Net income per share | 2.23 | 2.42 | 3.42 | 2.9 | 4.19 | |
Operating cash flow per share | 5.77 | 0.16 | 5.17 | 4.09 | 5.78 | |
Free cash flow per share | 5.54 | -0.29 | 4.78 | 3.52 | 5.29 | |
Cash per share | 3.1 | 2.03 | 2.68 | 2.08 | 2.47 | |
Book value per share | 13.25 | 15.66 | 19.18 | 19.63 | 24.01 | |
Tangible book value per share | -27.48 | -24.94 | -21.24 | -21.35 | -17.35 | |
Share holders equity per share | 13.25 | 15.66 | 19.18 | 19.63 | 24.01 | |
Interest debt per share | 42.83 | 41.94 | 37.6 | 38.04 | 29.12 | |
Market cap | 6.7B | 7.82B | 6.98B | 5.39B | 5.66B | |
Enterprise value | 9.1B | 10.24B | 9.1B | 7.55B | 7.5B | |
P/E ratio | 12.15 | 13.07 | 8.21 | 7.62 | 5.58 | |
Price to sales ratio | 7.08 | 8.84 | 6.5 | 5.16 | 5.89 | |
POCF ratio | 18.78 | 787.29 | 21.75 | 21.57 | 16.17 | |
PFCF ratio | 19.58 | -442.98 | 23.52 | 25.05 | 17.65 | |
P/B Ratio | 8.19 | 8.07 | 5.86 | 4.49 | 3.89 | |
PTB ratio | 8.19 | 8.07 | 5.86 | 4.49 | 3.89 | |
EV to sales | 9.63 | 11.59 | 8.48 | 7.22 | 7.81 | |
Enterprise value over EBITDA | 41.16 | 41.31 | 27.37 | 26.13 | 32.26 | |
EV to operating cash flow | 25.52 | 1.03K | 28.37 | 30.2 | 21.45 | |
EV to free cash flow | 26.62 | -580.37 | 30.67 | 35.07 | 23.41 | |
Earnings yield | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | |
Free cash flow yield | 0.05 | 0 | 0.04 | 0.04 | 0.06 | |
Debt to equity | 3.17 | 2.63 | 1.92 | 1.91 | 1.19 | |
Debt to assets | 0.58 | 0.56 | 0.5 | 0.5 | 0.37 | |
Net debt to EBITDA | 10.87 | 9.78 | 6.39 | 7.47 | 7.94 | |
Current ratio | 1.6 | 1.76 | 1.65 | 1.51 | 1.3 | |
Interest coverage | 4.42 | 5.51 | 7.4 | 6.98 | 6 | |
Income quality | 2.59 | 0.07 | 1.51 | 1.41 | 1.38 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.56 | 0.55 | 0.54 | 0.55 | 0.54 | |
Capex to operating cash flow | -0.04 | -2.78 | -0.08 | -0.14 | -0.08 | |
Capex to revenue | -0.02 | -0.03 | -0.02 | -0.03 | -0.03 | |
Capex to depreciation | -1.15 | -2.1 | -1.9 | -2.35 | -2.12 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 25.78 | 29.19 | 38.44 | 35.76 | 47.57 | |
ROIC | 0.05 | 0.05 | 0.07 | 0.05 | 0.09 | |
Return on tangible assets | 0.07 | 0.07 | 0.1 | 0.09 | 0.12 | |
Graham Net | -48.74 | -47.27 | -43.51 | -44.9 | -42.94 | |
Working capital | 384.7M | 480.3M | 435.28M | 331.31M | 212.41M | |
Tangible asset value | -1.7B | -1.54B | -1.32B | -1.31B | -1.05B | |
Net current asset value | -2.66B | -2.51B | -2.31B | -2.4B | -2.28B | |
Invested capital | 3.17 | 2.63 | 1.92 | 1.91 | 1.19 | |
Average receivables | 376.43M | 391.36M | 446.72M | 428.79M | 374.45M | |
Average payables | 210.46M | 231.6M | 247.15M | 235.9M | 235.43M | |
Average inventory | 492.65M | 473.83M | 456.19M | 413.22M | 387.61M | |
Days sales outstanding | 31.35 | 46.16 | 36.92 | 35.95 | 31.05 | |
Days payables outstanding | 46.28 | 51.29 | 52.26 | 40.7 | 54.7 | |
Days of inventory on hand | 94.55 | 105.08 | 87.05 | 75.66 | 80.71 | |
Receivables turnover | 2.87 | 1.95 | 2.44 | 2.5 | 2.9 | |
Payables turnover | 1.94 | 1.75 | 1.72 | 2.21 | 1.65 | |
Inventory turnover | 0.95 | 0.86 | 1.03 | 1.19 | 1.12 | |
ROE | 0.17 | 0.15 | 0.18 | 0.15 | 0.17 | |
Capex per share | -0.24 | -0.45 | -0.39 | -0.57 | -0.48 |
CROX Frequently Asked Questions
What is Crocs, Inc. stock symbol ?
Crocs, Inc. is a US stock , located in Broomfield of Co and trading under the symbol CROX
What is Crocs, Inc. stock quote today ?
Crocs, Inc. stock price is $121.08 today.
Is Crocs, Inc. stock public?
Yes, Crocs, Inc. is a publicly traded company.